Session 1 INTRODUCTION
Despite the global pandemic, we are excited to witness significant advances in ophthalmology in ocular and orbital oncology. The Stanford Retina faculty continue to reveal the newest innovations in ophthalmic imaging, pharmacotherapy, and surgery with key industry leaders, FDA regulators, clinicians, scientists and venture capitalists. Join an international panel of ocular oncologist, medical oncologists, corporate executives and scientists discuss the innovations in ocular oncology and the future of ocular melanoma.
SESSION 1 AGENDA